https://www.selleckchem.com/pr....oducts/epacadostat-i
Although inhaled corticosteroids (ICSs) are the recommended first-line therapy for asthma, determining whether to continue or discontinue ICS treatment in patients with mild asthma remains challenging for clinicians. Several studies have revealed that patients with mild-persistent asthma maintained a well-controlled state after ICS withdrawal. However, the long-term outcomes of ICS withdrawal have not yet been determined. To determine the possible clinical outcomes of the discontinuation of ICS in patients with well-contr
Like
Comment
Share
